Vanguard reports 5.28M shares (7.49%) in Insulet
Insulet Corp Schedule 13G: Vanguard Capital Management reports beneficial ownership of 5,277,842 shares of Common Stock, representing 7.49% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insulet Corp Schedule 13G: Vanguard Capital Management reports beneficial ownership of 5,277,842 shares of Common Stock, representing 7.49% of the class as of 03/31/2026. The filing lists 698,568 shares with sole voting power and 5,277,842 shares with sole dispositive power.
The filing is signed by Ashley Grim as Head of Global Fund Administration on 04/30/2026.
Insights
Vanguard holds a notable 7.49% stake in Insulet as a dispositive holder.
Vanguard Capital Management reports 5,277,842 shares beneficially owned with sole dispositive power and 698,568 shares carrying sole voting power. The filing follows Schedule 13G disclosure rules for passive or qualifying institutional investors.
Key dependencies include whether holdings are held in pooled funds or managed accounts; subsequent filings could change the stake. Timing shown: ownership as of 03/31/2026 and signature dated 04/30/2026.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
Sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Vanguard's 7.49% stake in Insulet (PODD) mean?
Who filed the Schedule 13G for PODD and when was it signed?
Does the Schedule 13G indicate Vanguard is a passive investor in PODD?
AI-generated analysis. How Rhea-AI works. Not financial advice.